Compare, Analyse SHASUN PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   ACTAVIS
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ACTAVIS
Dec-18
SHASUN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs9414,276-   
Low Rs469,577-   
Sales per share (Unadj.) Rs214.23,502.0-  
Earnings per share (Unadj.) Rs5.3-1,128.0-  
Cash flow per share (Unadj.) Rs15.8369.0-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.314,444.1-  
Shares outstanding (eoy) m56.62332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 9.6%   
Avg P/E ratio x13.1-10.6 -123.9%  
P/CF ratio (eoy) x4.432.3 13.7%  
Price / Book Value ratio x1.30.8 158.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9583,966,766 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM68,921.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,199.5-  
INCOME DATA
Net Sales Rs m12,1271,164,765 1.0%  
Other income Rs m22922,274 1.0%   
Total revenues Rs m12,3561,187,039 1.0%   
Gross profit Rs m1,00930,523 3.3%  
Depreciation Rs m594497,912 0.1%   
Interest Rs m41567,214 0.6%   
Profit before tax Rs m230-512,328 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,664 0.0%   
Tax Rs m-73-6,493 1.1%   
Profit after tax Rs m302-375,171 -0.1%  
Gross profit margin %8.32.6 317.5%  
Effective tax rate %-31.71.3 -2,498.2%   
Net profit margin %2.5-32.2 -7.7%  
BALANCE SHEET DATA
Current assets Rs m6,884477,726 1.4%   
Current liabilities Rs m8,456422,612 2.0%   
Net working cap to sales %-13.04.7 -273.9%  
Current ratio x0.81.1 72.0%  
Inventory Days Days6220 314.7%  
Debtors Days Days10866 162.2%  
Net fixed assets Rs m4,970131,845 3.8%   
Share capital Rs m1130-   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,0204,804,111 0.1%   
Long term debt Rs m1,8171,691,702 0.1%   
Total assets Rs m13,3477,509,919 0.2%  
Interest coverage x1.6-6.6 -23.5%   
Debt to equity ratio x0.60.4 170.9%  
Sales to assets ratio x0.90.2 585.8%   
Return on assets %5.4-4.1 -131.0%  
Return on equity %10.0-7.8 -128.1%  
Return on capital %13.3-4.8 -275.2%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398416,127 0.1%  
From Investments Rs m-1,635228,607 -0.7%  
From Financial Activity Rs m1,309-714,198 -0.2%  
Net Cashflow Rs m71-69,117 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.78 Rs / USD

Compare SHASUN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: DR. DATSONS LABS  TORRENT PHARMA  ORCHID PHARMA  VENUS REMEDIES  BIOCON   



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS